<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Medical Xpress news tagged with:melanoma</title>
            <link>https://medicalxpress.com/</link>
            <language>en-us</language> 
            <description>Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

                            <item>
                    <title>Eye cancer genes predetermine liver metastasis, study finds</title>
                    <description>Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more effectively treat the cancer and prevent metastasis. Researchers at Yale School of Medicine (YSM) have now identified biological markers for a rare, aggressive eye cancer that predict the likelihood of secondary tumors forming in the liver.</description>
                    <link>https://medicalxpress.com/news/2026-02-eye-cancer-genes-predetermine-liver.html</link>
                    <category></category>
                    <pubDate>Mon, 09 Feb 2026 09:59:52 EST</pubDate>
                    <guid isPermaLink="false">news689853541</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/surprised-eye.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Agent Orange exposure identified as a risk factor for rare skin cancer</title>
                    <description>A study of U.S. veterans led by investigators at Mass General Brigham has identified a possible link between exposure to the Agent Orange herbicide and a rare melanoma subtype less likely to be related to sun exposure. The authors of the study, published in JAMA Dermatology, say this link warrants further examination to inform diagnostic strategies for people who may be at a greater risk for acral melanoma.</description>
                    <link>https://medicalxpress.com/news/2026-02-agent-orange-exposure-factor-rare.html</link>
                    <category></category>
                    <pubDate>Wed, 04 Feb 2026 16:43:32 EST</pubDate>
                    <guid isPermaLink="false">news689445781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/vietnam-veterans.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A fungus living in our body can make melanoma more aggressive</title>
                    <description>Cancer is one of the causes responsible for the most deaths worldwide. In 2020, for example, it resulted in ten million deaths. It has been estimated that microorganism infections caused between 13 and 18% of these cases. Until now, the International Agency for Research on Cancer (IARC) has classified thirteen microorganisms as carcinogenic, which include viruses, bacteria and parasites. However, recent studies have shown that there are other microorganism types linked to cancer; some of them are fungi.</description>
                    <link>https://medicalxpress.com/news/2026-02-fungus-body-melanoma-aggressive.html</link>
                    <category></category>
                    <pubDate>Tue, 03 Feb 2026 14:40:01 EST</pubDate>
                    <guid isPermaLink="false">news689350099</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/it-has-been-clarified.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Chemo before 3 pm could be more successful for lung cancer patients</title>
                    <description>Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease progression than patients receiving treatment later in the day. The findings, published as part of a randomized phase 3 trial of 210 participants in Nature Medicine, suggest that scheduling therapy early in the day may offer a simple, cost-neutral way to enhance standard care.</description>
                    <link>https://medicalxpress.com/news/2026-02-chemo-pm-successful-lung-cancer.html</link>
                    <category></category>
                    <pubDate>Mon, 02 Feb 2026 17:50:03 EST</pubDate>
                    <guid isPermaLink="false">news689258826</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/chemotherapy.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Immunotherapy before surgery helps shrink tumors in patients with desmoplastic melanoma</title>
                    <description>New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and aggressive skin cancer, with immunotherapy before surgery can dramatically shrink or even eliminate tumors, sparing patients from more aggressive surgeries and preserving their quality of life.</description>
                    <link>https://medicalxpress.com/news/2026-01-immunotherapy-surgery-tumors-patients-desmoplastic.html</link>
                    <category></category>
                    <pubDate>Thu, 29 Jan 2026 05:00:01 EST</pubDate>
                    <guid isPermaLink="false">news688752048</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/4-skin.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New approach offers hope for people with rare eye cancer</title>
                    <description>Researchers at Queen Mary&#039;s Barts Cancer Institute have found a more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients to live longer.</description>
                    <link>https://medicalxpress.com/news/2026-01-approach-people-rare-eye-cancer.html</link>
                    <category></category>
                    <pubDate>Thu, 22 Jan 2026 10:54:10 EST</pubDate>
                    <guid isPermaLink="false">news688301581</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/eyeball.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Report reveals 5-year relative survival rates for all cancers up to 70% in the US</title>
                    <description>Five-year relative survival rates for all cancers combined have increased to 70% for people diagnosed during 2015 to 2021 in the United States, according to the &quot;Cancer Statistics, 2026,&quot; report, published in CA: A Cancer Journal for Clinicians.</description>
                    <link>https://medicalxpress.com/news/2026-01-reveals-year-survival-cancers.html</link>
                    <category></category>
                    <pubDate>Tue, 13 Jan 2026 17:40:01 EST</pubDate>
                    <guid isPermaLink="false">news687521386</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/acs-report-five-year-r.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>&#039;Don&#039;t use them&#039;: Tanning beds triple skin cancer risk, study finds</title>
                    <description>When Heidi Tarr was a teenager, she used a tanning bed several times a week with her friends because they all wanted to glow like a celebrity.</description>
                    <link>https://medicalxpress.com/news/2025-12-dont-tanning-beds-triple-skin.html</link>
                    <category></category>
                    <pubDate>Sun, 28 Dec 2025 14:00:01 EST</pubDate>
                    <guid isPermaLink="false">news684831221</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/realistic-photo-of-ind.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Indoor tanning makes youthful skin much older on a genetic level</title>
                    <description>Tanning bed users are known to have a higher risk of skin cancer, but for the first time researchers have found that young indoor tanners undergo genetic changes that can lead to more mutations in their skin cells than people twice their age.</description>
                    <link>https://medicalxpress.com/news/2025-12-indoor-tanning-youthful-skin-older.html</link>
                    <category></category>
                    <pubDate>Sat, 27 Dec 2025 11:10:02 EST</pubDate>
                    <guid isPermaLink="false">news684736715</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/tanning-bed.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Thick melanoma tumors may be linked to poorer survival than some metastatic cases</title>
                    <description>The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but localized tumors have poorer long-term survival than those with melanoma that has spread to nearby lymph nodes, according to a large Swedish registry study from the University of Gothenburg.</description>
                    <link>https://medicalxpress.com/news/2025-12-thick-melanoma-tumors-linked-poorer.html</link>
                    <category></category>
                    <pubDate>Thu, 18 Dec 2025 10:03:21 EST</pubDate>
                    <guid isPermaLink="false">news685274581</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/crowded-beach-from-dro-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Ultrasensitive liquid biopsy affective in predicting and monitoring immunotherapy response, study shows</title>
                    <description>Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d&#039;Hebron Institute of Oncology (VHIO), which forms part of the Vall d&#039;Hebron Campus, underscore the efficacy of analyzing circulating tumor DNA (ctDNA) using a highly sensitive liquid biopsy platform for evaluating early response, predicting survival and tumor progression in patients with advanced cancers who received treatment with immunotherapy in the context of phase 1 clinical trials.</description>
                    <link>https://medicalxpress.com/news/2025-12-ultrasensitive-liquid-biopsy-affective-immunotherapy.html</link>
                    <category></category>
                    <pubDate>Wed, 17 Dec 2025 21:10:05 EST</pubDate>
                    <guid isPermaLink="false">news685197278</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/biopsy.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation</title>
                    <description>The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory biomaterial-based cancer vaccine, in a cohort of 21 patients with stage 4 metastatic melanoma, was concluded with positive outcomes that encourage future vaccine developments and trials to test them in combination with immune checkpoint inhibitor therapies.</description>
                    <link>https://medicalxpress.com/news/2025-12-clinical-trial-personalized-cancer-vaccine.html</link>
                    <category></category>
                    <pubDate>Mon, 15 Dec 2025 15:29:42 EST</pubDate>
                    <guid isPermaLink="false">news685034941</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/clinical-trial-of-pers.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tanning beds mutate skin cells far beyond the reach of ordinary sunlight, study shows</title>
                    <description>Tanning bed use is tied to almost a three-fold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new study led by Northwestern Medicine and University of California, San Francisco.</description>
                    <link>https://medicalxpress.com/news/2025-12-tanning-beds-mutate-skin-cells.html</link>
                    <category></category>
                    <pubDate>Fri, 12 Dec 2025 14:00:06 EST</pubDate>
                    <guid isPermaLink="false">news684678541</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/tanning-beds-triple-me.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Lower doses of immunotherapy for skin cancer give better results, study suggests</title>
                    <description>According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National Cancer Institute.</description>
                    <link>https://medicalxpress.com/news/2025-12-doses-immunotherapy-skin-cancer-results.html</link>
                    <category></category>
                    <pubDate>Sun, 07 Dec 2025 19:10:04 EST</pubDate>
                    <guid isPermaLink="false">news684084901</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/skin-5.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tattoos could be a risk factor for melanoma</title>
                    <description>An increasing number of Swedes are getting tattoos and Sweden&#039;s population is now one of the most tattooed in Europe. At the same time, the incidence of melanoma is increasing. A new epidemiological study from Lund University in Sweden suggests that tattoos could be a risk factor for melanoma.</description>
                    <link>https://medicalxpress.com/news/2025-11-tattoos-factor-melanoma.html</link>
                    <category></category>
                    <pubDate>Tue, 25 Nov 2025 15:50:02 EST</pubDate>
                    <guid isPermaLink="false">news683307428</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/colorful-tattoos.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How cancer cells &#039;break through&#039; tight tissue gaps</title>
                    <description>Aggressive cancer cells are masters of movement. When they spread through the body, they cause metastasis, which significantly reduces a person&#039;s chance of survival. For this spreading to take place, they can switch between different cell states—behaviors of cells—that move with different strategies.</description>
                    <link>https://medicalxpress.com/news/2025-11-cancer-cells-tight-tissue-gaps.html</link>
                    <category></category>
                    <pubDate>Tue, 18 Nov 2025 11:00:06 EST</pubDate>
                    <guid isPermaLink="false">news682599761</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/breakthrough-study-sho.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Skin cancer cluster found in 15 Pennsylvania counties with or near farmland</title>
                    <description>Counties in Pennsylvania that contained or were near cultivated cropland had significantly higher melanoma rates compared to other regions, according to a new study led by scientists at Penn State.</description>
                    <link>https://medicalxpress.com/news/2025-11-skin-cancer-cluster-pennsylvania-counties.html</link>
                    <category></category>
                    <pubDate>Fri, 14 Nov 2025 16:00:02 EST</pubDate>
                    <guid isPermaLink="false">news682332361</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/skin-cancer-cluster-fo.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Deep learning system could transform skin cancer detection with near-perfect accuracy</title>
                    <description>Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they often overlook crucial patient information (like age, gender, or where on the body the lesion appears) that can improve diagnostic accuracy. This highlights the importance of multimodal fusion models that can enable high precision diagnosis.</description>
                    <link>https://medicalxpress.com/news/2025-11-deep-skin-cancer-accuracy.html</link>
                    <category></category>
                    <pubDate>Fri, 14 Nov 2025 12:33:04 EST</pubDate>
                    <guid isPermaLink="false">news682345981</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/study-by-incheon-natio.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How the microbiome and a fiber-rich diet help fight melanoma</title>
                    <description>Scientists at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have uncovered how the gut microbiota help the immune system fight melanoma, explaining why patients with a fiber-rich diet and balanced gut bacteria tend to respond better to cancer immunotherapies.</description>
                    <link>https://medicalxpress.com/news/2025-11-microbiome-fiber-rich-diet-melanoma.html</link>
                    <category></category>
                    <pubDate>Tue, 11 Nov 2025 11:27:04 EST</pubDate>
                    <guid isPermaLink="false">news682082821</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/new-research-uncovers-19.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Triggering cell death in metastatic melanoma may pave the way for new cancer treatments</title>
                    <description>Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor protein 1 (FSP1)—a surprising metabolic dependency that could open the door to a new class of cancer treatments, according to a new study led by Harvard T.H. Chan School of Public Health.</description>
                    <link>https://medicalxpress.com/news/2025-11-triggering-cell-death-metastatic-melanoma.html</link>
                    <category></category>
                    <pubDate>Wed, 05 Nov 2025 11:00:19 EST</pubDate>
                    <guid isPermaLink="false">news681471891</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/patient-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study finds promising first evidence of targeted therapy for NRAS-mutant melanoma</title>
                    <description>New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and activate the immune system, offering the first targeted approach for patients with NRAS-mutant melanoma, an aggressive form of skin cancer with limited treatment options beyond immune checkpoint inhibitors.</description>
                    <link>https://medicalxpress.com/news/2025-11-evidence-therapy-nras-mutant-melanoma.html</link>
                    <category></category>
                    <pubDate>Tue, 04 Nov 2025 23:20:01 EST</pubDate>
                    <guid isPermaLink="false">news681496443</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/tumor.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Challenging conventional wisdom on a common cause of melanoma</title>
                    <description>University of Queensland researchers have found that a genetic mutation that causes melanoma can lie dormant in healthy skin, a finding that could improve screening of areas more prone to the disease.</description>
                    <link>https://medicalxpress.com/news/2025-10-conventional-wisdom-common-melanoma.html</link>
                    <category></category>
                    <pubDate>Wed, 29 Oct 2025 20:50:01 EDT</pubDate>
                    <guid isPermaLink="false">news680964080</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/melanoma-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Inhibiting a problematic protein helps immunotherapies, CAR T-cell therapy to fight off melanoma more effectively</title>
                    <description>Melanoma, the deadliest form of skin cancer, can&#039;t always be removed with a scalpel.</description>
                    <link>https://medicalxpress.com/news/2025-10-inhibiting-problematic-protein-immunotherapies-car.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Oct 2025 22:50:01 EDT</pubDate>
                    <guid isPermaLink="false">news680888044</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/unc-researchers-discov.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Promising new drug combination for melanoma patients resistant to treatment</title>
                    <description>Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard immunotherapy, treatment options are painfully limited. Vanderbilt researchers led by Professor Emerita of Pharmacology Ann Richmond have discovered a promising new drug combination that targets three key pathways at once and that may help these treatment-resistant patients respond once again to the body&#039;s own immune defenses.</description>
                    <link>https://medicalxpress.com/news/2025-10-drug-combination-melanoma-patients-resistant.html</link>
                    <category></category>
                    <pubDate>Mon, 27 Oct 2025 15:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news680795106</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/promising-new-drug-com-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New genomic test could spare some people with melanoma from lymph node biopsy surgery</title>
                    <description>A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes—a finding that could guide treatment decisions and help many people avoid lymph node biopsy surgery. The study results are published in JAMA Surgery.</description>
                    <link>https://medicalxpress.com/news/2025-10-genomic-people-melanoma-lymph-node.html</link>
                    <category></category>
                    <pubDate>Wed, 22 Oct 2025 15:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news680363407</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/draw-3d-illustration-o.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Recurrence-free survival longer with nivolumab than ipilimumab in melanoma: Study</title>
                    <description>For patients with resected stage IIIB-C or stage IV melanoma, recurrence-free survival is longer with nivolumab than ipilimumab, according to a study published online Oct. 18 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncology, held from Oct. 17 to 21 in Berlin.</description>
                    <link>https://medicalxpress.com/news/2025-10-recurrence-free-survival-longer-nivolumab.html</link>
                    <category></category>
                    <pubDate>Tue, 21 Oct 2025 15:59:02 EDT</pubDate>
                    <guid isPermaLink="false">news680281141</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/recurrence-free-surviv.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer</title>
                    <description>Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.</description>
                    <link>https://medicalxpress.com/news/2025-10-covid-mrna-vaccine-immune-response.html</link>
                    <category></category>
                    <pubDate>Sun, 19 Oct 2025 08:50:03 EDT</pubDate>
                    <guid isPermaLink="false">news679922110</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/study-finds-covid-19-m.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>mRNA-based COVID vaccines generate improved responses to immunotherapy</title>
                    <description>Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.</description>
                    <link>https://medicalxpress.com/news/2025-10-mrna-based-covid-vaccines-generate.html</link>
                    <category></category>
                    <pubDate>Sun, 19 Oct 2025 08:50:01 EDT</pubDate>
                    <guid isPermaLink="false">news679926880</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/covid-vaccine.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>&#039;Craters&#039; on surface of melanoma cells mark tumor-killing hotspots, study reveals</title>
                    <description>New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, becoming major sites for tumor killing. These craters could serve as good markers for immunotherapy success.</description>
                    <link>https://medicalxpress.com/news/2025-10-craters-surface-melanoma-cells-tumor.html</link>
                    <category></category>
                    <pubDate>Fri, 17 Oct 2025 11:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news679824422</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/craters-on-surface-of.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Melanoma risk calculator now factors in 16 personal traits and regional UV exposure</title>
                    <description>QIMR Berghofer has unveiled the next-generation of its world-leading melanoma risk prediction calculator to better help Australians take action against one of the country&#039;s most deadly, costly, and common cancers that claims more lives each year than the national road toll.</description>
                    <link>https://medicalxpress.com/news/2025-09-melanoma-factors-personal-traits-regional.html</link>
                    <category></category>
                    <pubDate>Mon, 29 Sep 2025 15:45:12 EDT</pubDate>
                    <guid isPermaLink="false">news678379506</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/skin-cancer.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
